Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Topical fixed-dose triple combination gel of Clindamycin Phosphate (1.2%), Adapalene (0.15%), and Benzoyl Peroxide (3.1%)
: This study aims to determine the efficacy of fixed dose tripl
Sponsors
Dr Harjot Singh
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients of acne vulgaris (Grade 1 and Grade 2) 2)Patients of 12-50 years age
Exclusion criteria
Exclusion criteria: ?Pregnant or lactating women ?Patients with signs and symptoms of hyperandrogenism ?Patients having hypothyroidism or any other serious systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage improvement and reduction in the total lesion count from baseline, and reduction in total lesion count assessed through clinical photography Timepoint: Assessment will be done at baseline visit (week 0), 3 weeks ,6 weeks , 9 weeks , 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient-reported outcomes: Evaluation of treatment satisfaction and improvement in acne. 2. Adverse effects: Monitoring and categorization of adverse events in triple combination therapy. Timepoint: Baseline (Week 0) ? Before starting treatment Week 3 ? First follow-up Week 6 ? Second follow-up Week 9 ? Third follow-up Week 12 ? Final follow-up/end of study | — |
Countries
India
Contacts
Public ContactDr Harjot Singh
Government medical college and hospital ,chandigarh
Outcome results
None listed